Thrilled this is published!! All about what you need to know about digital media, AI and gamification for #MedEd! Come to our session Monday 6/2 11:30am CST to learn more! @jhundal.bsky.social #ASCO25

When we’re back on Hem/Onc consults together #cofellows @uthealthsamda.bsky.social @uthealthsahospital.bsky.social @uthealthsa.bsky.social

Shamelessly answering overnight calls out of breath as I do my long run along the Riverwalk tonight @uthealthsa.bsky.social #wellness #WorkLifeBalance #fellowship

Looking back at 2024, here are some highlights: 1. Completed IM residency 2. Started hematology/oncology fellowship 3. Moved to a new city 4. Found camaraderie and friendship among my cofellows and colleagues 5. Grateful for all my family, friends, and mentors who stood by me Here’s to 2025!

That’s a wrap #SABCS24! More amazing highlights from @sabcs.bsky.social @beverlymoy.bsky.social @dradityabardia @LesleyWu @lauraspringmd.bsky.social @SethWander @JayParekhhh

A few days late to post this! It was so great having the opportunity to meet and chat with the @oncbrothers.bsky.social at @sabcs.bsky.social @uthealthsamda.bsky.social @LSOM_HemOnc

#SABCS24 Day 3 Highlights #CommunityOnc: 1. #EUROPA: ET vs XRT HR+ ≥70 yrs 2. #PATINA: CDK4/6 HR+ HER2+ new SoC 3. #COMET: DCIS 4. #SUPREMO: XRT post mastectomy 5. #INSEMA: ALNBx @sabcs.bsky.social @theaacr.bsky.social @drsarahsammons.bsky.social @erikahamilton9.bsky.social

Social media interns @jhundal.bsky.social for @cosmocollab.bsky.social catching up at @sabcs.bsky.social

Starting now! Estrogen Receptor Mutations in HR+ Breast Cancer with @vkaklamani.bsky.social @lauraspringmd.bsky.social @elmayermd.bsky.social @sabcs.bsky.social @uthealthsamda.bsky.social

Great discussion on the most recent breast cancer data with @precisca_ @DrReshmaMahtani @AnneODeaMD @jhundal.bsky.social @sabcs.bsky.social

Meeting up with my Caris POA mentor, Dr. Cynthia Ma @sabcs.bsky.social @uthealthsamda.bsky.social

Annual SABCS @sabcs.bsky.social photo with the best PD @uthealthsamda.bsky.social

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial | Breast Cancer | JAMA | JAMA Network #SABCS24 @oncoalert.bsky.social

Reuniting with @MGHBreastOnc at #SABCS24 @sabcs.bsky.social @beverlymoy.bsky.social @lauraspringmd.bsky.social

The OncoAlert🚨 hashtag#SABCS24 DAY2 Newsletter Out tomorrow 7am REGISTER AT www.OncoAlert360.com OR buff.ly/48Xpgz0 Discussing ✅EMBER3 (Out on @NEJM ) ✅Olympia ✅PRO B ✅SHR-A1811 ✅PHILA ✅Risk Reducing Surg in yBC patients w/BRCA mut @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social

Straight out of clinic —> to #SABCS24 @sabcs.bsky.social @uthealthsamda.bsky.social